More about: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4

被引:26
作者
Rebbeck, TR [1 ]
机构
[1] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA
关键词
D O I
10.1093/jnci/92.1.76
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:76 / 76
页数:1
相关论文
共 7 条
[1]   Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 - Response [J].
Amirimani, B ;
Walker, AH ;
Weber, BL ;
Rebbeck, TR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (18) :1588-1590
[2]   Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 [J].
Ando, Y ;
Tateishi, T ;
Sekido, Y ;
Yamamoto, T ;
Satoh, T ;
Hasegawa, Y ;
Kobayashi, S ;
Katsumata, Y ;
Shimokata, K ;
Saito, H .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (18) :1587-1588
[3]   Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4 [J].
Ball, SE ;
Scatina, JA ;
Kao, J ;
Ferron, GM ;
Fruncillo, R ;
Mayer, P ;
Weinryb, I ;
Guida, M ;
Hopkins, PJ ;
Warner, N ;
Hall, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (03) :288-294
[4]  
Paris PL, 1999, CANCER EPIDEM BIOMAR, V8, P901
[5]   Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 [J].
Rebbeck, TR ;
Jaffe, JM ;
Walker, AH ;
Wein, AJ ;
Malkowicz, SB .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (16) :1225-1229
[6]  
Walker A H, 1998, Hum Mutat, V12, P289
[7]   Interindividual differences in hepatic expression of CYP3A4:: Relationship to genetic polymorphism in the 5′-upstream regulatory region [J].
Westlind, A ;
Löfberg, L ;
Tindberg, N ;
Andersson, TB ;
Ingelman-Sundberg, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 259 (01) :201-205